Evidence map›Paper›PMID 40325048›Full record

ArticleScientific reports2025

Trends in liver cancer rehabilitation needs, disease burden, and attributable risk factors in China, 1990-2021.

Xiangping Han, Lei He, Shaoying Li, Yuxing Zhu

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xiangping HanDepartment of Oncology II, Zhumadian Central Hospital, No. 747, West Section of Zhonghua Road, Yicheng District, Zhumadian City, 463000, Henan, China. hanxiangp123@163.com.
Lei HeThird Department of Psychological Medicine, Zhumadian Second People's Hospital, No. 51 Xuesong Road, Zhumadian City, 463000, Henan Province, China.
Shaoying LiDepartment of Oncology II, Zhumadian Central Hospital, No. 747, West Section of Zhonghua Road, Yicheng District, Zhumadian City, 463000, Henan, China.
Yuxing ZhuThird Department of Psychological Medicine, Zhumadian Second People's Hospital, No. 51 Xuesong Road, Zhumadian City, 463000, Henan Province, China.

Funding

Zhumadian Science and Technology Think Tank Research zmdkjzk-2024-15
6 · The paper itself

Abstract

This study investigates trends in liver cancer rehabilitation needs, disease burden, and attributable risk factors in China from 1990 to 2021 using data from the Global Burden of Disease Study 2021. Key metrics included age-standardized prevalence (ASPR), years lived with disability (YLDs), and risk factor attribution. Between 1990 and 2021, the number of liver cancer patients requiring rehabilitation surged by 100.1% (132,779 to 265,539 cases), with YLDs rising by 102.8% (22,981 to 46,602). While ASPR and age-standardized YLD rates (ASYR) showed modest declines (ASPR: - 0.1% annual change; ASYR: - 0.23%), males exhibited a disproportionately higher burden, with 2021 cases and YLDs 2.98- and 2.74-fold greater than females, respectively. Risk factor analysis revealed smoking (14.0%), drug use (11.5%), and alcohol consumption (11.4%) as primary contributors, while metabolic factors like high BMI (7.5%) and fasting plasma glucose (1.9%) demonstrated accelerating impacts (YLDs EAPC: + 4.47% and + 1.31%, respectively). Aging populations and shifting etiologies drove increased rehabilitation demands, particularly among those ≥ 80 years. These findings underscore urgent needs for gender-specific interventions targeting modifiable risks and integrated nursing rehabilitation strategies to mitigate China's growing liver cancer burden.

Indexed as

Cost of IllnessLiver NeoplasmsAdultAgedAged, 80 and overChinaFemaleGlobal Burden of DiseaseHumansMaleMiddle AgedPrevalenceRisk FactorsDisease burdenGBDLiver cancerNursingRehabilitation needsRisk factorsTrends

Identifiers

PMID40325048
PMCPMC12053601

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.